Seniors in Medicare are about to get landmark obesity drug coverage — but many may not know it yet
Why Eli Lilly Gained 7% On Friday
Eli Lilly Leads 5 Stocks Near Buy Points As The Market Rally Rotates
Is Eli Lilly Stock an Undervalued Healthcare Stock to Buy?
Why Eli Lilly Stock Jumped to a New All-Time High Today
Lilly, J&J and AbbVie Hit New Highs
Eli Lilly shares rise after EU panel backs expanded use of Jaypirca
Eli Lilly (LLY) is a Top-Ranked Momentum Stock: Should You Buy?
Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy
Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy
Eli Lilly shares rise after EU panel backs expanded use of Jaypirca
What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management
Lilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly
Trump visits Mack Trucks plant in battleground Pennsylvania district to tout economic agenda as midterms loom
Biotech's Silent Resurgence (5-Year Base Breakout)
How Eli Lilly Became a $1 Trillion Company
Eli Lilly says Trump pricing policy will affect obesity drug launches in Europe
Fund manager names 3 non-AI stocks to own as Intel, AMD sink amid broader tech rout
Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock
3 Monster Stocks to Hold for the Next 10 Years
Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk
Eli Lilly vs Pfizer: One Owns the Obesity Market Today, The Other Paid to Compete Tomorrow
Lilly declares third-quarter 2026 dividend
Lilly declares third-quarter 2026 dividend
13 Stocks Are Members of the $1 Trillion Club. Here's the Best Pick to Buy Right Now.
Lilly's 7 Acquisitions in 3 Months: Which Will Be the Biggest Game-Changer for the Pharma Giant?
3 Penny Stocks Under $5 Backed by Real Revenue Growth
3 Reasons to Buy Eli Lilly Stock
Vertex Has a Head Start in Non-Opioid Pain. Eli Lilly Just Spent Billions to Catch Up.
Prediction: Eli Lilly Will Trade at $1,200 on This Date
Novo Nordisk Stock Rally as Owner Unveils $69 Million Obesity Research Push
Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know
Can Pfizer Take Share From Lilly & Novo Nordisk in the Obesity Space?
3 Stocks Doing the Heavy Lifting in Healthcare's Rebound
Eli Lilly Takes Another Stab at the Market for Painkillers. This Attempt Might Work.
Eli Lilly vs. Novo Nordisk: Better Obesity Drug Stock?
Health Care ETFs: XLV Delivers Low Fees and Solid Returns
Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL
Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL
Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting
Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting
Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know
Eli Lilly Stock Hits Buy Zone As Earnings Soar 156%. Funds Are Loading Up.
Here's Why Eli Lilly (LLY) is a Strong Growth Stock
Forget Eli Lilly and Company: As June Volatility Rocks High-Flyers, This Stock Is a No-Brainer Buy
American Express, Live Nation And A Health Care Stock: CNBC's 'Final Trades'
Eli Lilly vs Novo Nordisk: The Battle for Obesity Drug Supremacy
Pharma and Biotech M&A Boom Accelerates as Companies Expand Pipelines
MU, GOOGL, LLY & Other Stocks Andrew Arons is Watching This Summer